# University of Gdańsk

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/university-of-gdansk/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 60.6 |
| Citations | 1,187,149 |
| City | Gdansk |
| Country | PL |
| Description | University of Gdańsk is a research organisation in Gdansk, PL. OpenAlex records 42,447 works and 1,187,149 citations for it. 7,420 researchers list it as their most recent affiliation. |
| Homepage | https://ug.edu.pl |
| OpenAlex ID | https://openalex.org/I40413290 |
| Region | Pomerania |
| Researchers | 7,420 |
| ROR ID | https://ror.org/011dv8m48 |
| Type | education |
| Works | 42,447 |

## University papers

- [Alectinib versus Crizotinib in Untreated <i>ALK</i>-Positive Non–Small-Cell Lung Cancer](https://scholariq.org/papers/alectinib-versus-crizotinib-in-untreated-i-alk-i-positive-non-small-cell-lung/)
- [Updated overall survival and final progression-free survival data for patients with treatment-naive advanced ALK-positive non-small-cell lung cancer in the ALEX study](https://scholariq.org/papers/updated-overall-survival-and-final-progression-free-survival-data-for-patients/)
- [Rociletinib in <i>EGFR</i>-Mutated Non–Small-Cell Lung Cancer](https://scholariq.org/papers/rociletinib-in-i-egfr-i-mutated-non-small-cell-lung-cancer/)
- [Liquid Biopsy for Advanced NSCLC: A Consensus Statement From the International Association for the Study of Lung Cancer](https://scholariq.org/papers/liquid-biopsy-for-advanced-nsclc-a-consensus-statement-from-the-international/)
- [Entrectinib in ROS1 fusion-positive non-small-cell lung cancer: integrated analysis of three phase 1–2 trials](https://scholariq.org/papers/entrectinib-in-ros1-fusion-positive-non-small-cell-lung-cancer-integrated/)
- [Tarlatamab for Patients with Previously Treated Small-Cell Lung Cancer](https://scholariq.org/papers/tarlatamab-for-patients-with-previously-treated-small-cell-lung-cancer/)
- [Alectinib in Resected <i>ALK</i> -Positive Non–Small-Cell Lung Cancer](https://scholariq.org/papers/alectinib-in-resected-i-alk-i-positive-non-small-cell-lung-cancer/)
- [Alectinib versus chemotherapy in crizotinib-pretreated anaplastic lymphoma kinase (ALK)-positive non-small-cell lung cancer: results from the phase III ALUR study](https://scholariq.org/papers/alectinib-versus-chemotherapy-in-crizotinib-pretreated-anaplastic-lymphoma/)
- [Managing cancer patients during the COVID-19 pandemic: an ESMO multidisciplinary expert consensus](https://scholariq.org/papers/managing-cancer-patients-during-the-covid-19-pandemic-an-esmo-multidisciplinary/)
- [Repotrectinib in <i>ROS1</i> Fusion–Positive Non–Small-Cell Lung Cancer](https://scholariq.org/papers/repotrectinib-in-i-ros1-i-fusion-positive-non-small-cell-lung-cancer/)

## University top topics

Showing 8 of 11.

- [Quantum Information and Cryptography](https://scholariq.org/topics/quantum-information-and-cryptography/)
- [Quantum Mechanics and Applications](https://scholariq.org/topics/quantum-mechanics-and-applications/)
- [Botany and Plant Ecology Studies](https://scholariq.org/topics/botany-and-plant-ecology-studies/)
- [Quantum Computing Algorithms and Architecture](https://scholariq.org/topics/quantum-computing-algorithms-and-architecture/)
- [Plant and animal studies](https://scholariq.org/topics/plant-and-animal-studies/)
- [Photochemistry and Electron Transfer Studies](https://scholariq.org/topics/photochemistry-and-electron-transfer-studies/)
- [Bacteriophages and microbial interactions](https://scholariq.org/topics/bacteriophages-and-microbial-interactions/)
- [Bacterial Genetics and Biotechnology](https://scholariq.org/topics/bacterial-genetics-and-biotechnology/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.